A phase I/II trial of induction cisplatin and docetaxel followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for locally advanced squamous cell carcinoma of the head and neck
Phase of Trial: Phase I/II
Latest Information Update: 14 Feb 2011
At a glance
- Drugs Amifostine; Cisplatin; Docetaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 14 Feb 2011 Aventis Pharmaceuticals as company and lead trial centres identified as reported by ClinicalTrials.gov.
- 10 Nov 2006 New trial record.